Related Experiment Video
Updated: May 22, 2025

Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis
Published on: September 11, 2019
Human Immunodeficiency Virus-associated Heart Disease in Nigerian Children: A Persistent and Difficult Clinical
1Department of Paediatrics, College of Medicine, University of Nigeria, Enugu Campus, Enugu, Nigeria.
Insights
Childhood heart disease is a significant complication of human immunodeficiency virus (HIV) infection, affecting 38.2%–75.9% globally. Management is challenging in developing countries due to limited resources and comorbidities.
Area of Science:
- Cardiology
- Infectious Diseases
- Pediatrics
Background:
- Heart disease is a common end-organ damage in patients with human immunodeficiency virus (HIV)/AIDS.
- The global incidence of HIV-associated heart disease ranges from 20% to 40%.
Purpose of the Study:
- To review the prevalence and management challenges of childhood HIV-associated heart disease in a developing country.
- To highlight the need for routine cardiovascular screening in children with HIV.
Main Methods:
- A literature search was conducted using keywords such as 'HIV', 'heart disease', 'HAART', 'end organ involvement in HIV', 'echocardiography', and 'children'.
- Data on prevalence and management challenges were extracted from published studies.
Main Results:
- Global prevalence of HIV-associated heart disease is high (38.2%–75.9%), including left ventricular (LV) diastolic and systolic dysfunction, dilated cardiomyopathy, pericardial effusion, and LV hypertrophy.
- Specific echocardiographic findings like elevated mitral valve peak E/A ratio and prolonged deceleration time were noted in affected children.
- Management challenges include a lack of echocardiographic expertise and difficulties in using diuretics due to comorbidities like anemia and diarrheal disease.
Conclusions:
- HIV-associated heart disease is a prevalent condition in children, presenting significant management challenges in developing nations.
- Routine screening for cardiovascular abnormalities at baseline and during follow-up is crucial for early detection and management.
Abstract:
Heart disease is one of the end organ damages noticed in patients with human immunodeficiency virus (HIV)/AIDS. Its incidence globally is 20%-40%. At least 300,000 children were newly infected as of 2020 in Nigeria. This review highlights the prevalence and management challenges of childhood HIV-associated heart disease in a developing country. A search for published data on HIV-associated heart disease was done through several search engines. Keywords such as 'HIV', 'heart disease', 'HAART', 'end organ involvement in HIV', 'echocardiography' and 'children' were used. The global prevalence of HIV-associated heart disease ranged from 38.2% to 75.9%. This includes left ventricular (LV) diastolic dysfunction (30.7%-36.4%); mean mitral valve peak E/A ratio 2.09 ± 0.46, Deceleration time (DT) 230.66 ± 36.27 ms and in vitro release test 110.40 ± 10.12 ms were higher in these children than controls (P < 0.001). LV systolic dysfunction was seen in 33.7%-35.4%, dilated cardiomyopathy (6.8%-33.7%) and pericardial effusion (4.5%-14.5%). Other cardiac abnormalities were LV hypertrophy, 7.5%-10%. Management challenges include a dearth of two-dimensional echocardiographic competence in Nigeria, as services are unavailable in some tertiary centres. The comorbidity with anaemia and low systemic vascular resistance from diarrhoeal disease in these children makes diuretics difficult to use. HIV-associated heart disease is one of the common end organ involvements in children with some management challenges. There is a need for routine screening for cardiovascular abnormality at baseline and at follow-up.
More Related Videos
Related Concept Videos
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Sexually Transmitted Infections
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...

